PR Newswire

    SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its

    JOHANNESBURG, Nov. 13, 2026 /PRNewswire/ — As distribution network services grew increasingly complex, Cemig’s distribution devices relied primarily on leased public networks for data backhaul. However, this model presented significant risks.